English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Vifor Pharma
Press release submission
| Dec 10, 2021
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Nicholas Gueguen
| Aug 13, 2017
Vifor Pharma begins new tests of Ferinject in patients with heart failure, iron deficiency
Robert Hadley
| Apr 28, 2017
Vifor Pharma offers grants aimed at combating iron deficiency
Gene Johnson
| Mar 1, 2017
Vifor buys rights to sell renal treatment in most of Asia
Carol Ostrow
| Feb 16, 2017
Swiss company holds iron deficiency to the fire
Keri Carbaugh
| Jan 6, 2017
Kidney Health Alliance expands to include CCX140
Amanda Rupp
| Jun 11, 2016
Vifor Pharma grants Pfizer commercialization rights
Amanda Rupp
| May 25, 2016
Vifor Pharma buys rights to rare renal disease treatment
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Regulatory
C.D. Marsden
| Apr 18, 2025
FDA Commissioner Makary: 'We are removing industry members—Pharma members—from FDA advisory committees'
